Internal Medicine, Medical Oncology · Rutherford, NJ
NPI
1891766721
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
201 Route 17 Fl 11
Rutherford, NJ, 07070
Phone (201) 500-4958
Groups this clinician bills Medicare through
Medicare paid, 2024
$706K
68,596 services
Medicare patients, 2024
201
Average age 74
Drug cost, 2024
$3.5M
740 prescriptions
Company payments, 2025
$616
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jin S Lee was code J1439 (injection, ferric carboxymaltose, 1 mg), 32,250 times for 21 patients. In total Jin S Lee billed 68,596 services in 78 codes, and Medicare paid $706K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 32,250 | 21 | $0.87 | $28K |
| 99214 Office E&M - Established | Office | 418 | 127 | $114.47 | $48K |
| 36415 Venipuncture Blood Collection | Office | 392 | 125 | $8.65 | $3,391 |
| 85025 Blood Count | Office | 335 | 103 | $7.61 | $2,549 |
| 96372 Injection Administration | Office | 264 | 43 | $13.03 | $3,440 |
| 99233 Hospital E&M - Subsequent | Facility | 209 | 34 | $107.89 | $23K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 131 | 24 | $0.97 | $128 |
| 96365 Intravenous Infusion, Hydration | Office | 123 | 35 | $59.74 | $7,348 |
| 99215 Office E&M - Established | Office | 114 | 54 | $152.16 | $17K |
| 96367 Intravenous Infusion, Hydration | Office | 64 | 14 | $26.68 | $1,708 |
| 96413 Chemotherapy Administration | Office | 46 | 12 | $120.49 | $5,543 |
| 99223 Hospital E&M - Initial | Facility | 31 | 31 | $158.07 | $4,900 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 14 | $14.49 | $391 |
| 99204 Office E&M - New | Office | 26 | 26 | $153.99 | $4,004 |
| 99205 Office E&M - New | Office | 11 | 11 | $188.39 | $2,072 |
By year: 2022 $544K for 55,739 services; 2023 $1.0M for 54,659 services; 2024 $706K for 68,596 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 392 | 125 | $8.65 | $3,391 |
| 85025 Blood Count | 335 | 103 | $7.61 | $2,549 |
Medicare prescription drug claims, 2024
In 2024, the drug Jin S Lee prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 81 prescriptions and refills. In total Jin S Lee wrote 740 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 81 | 88 | 14 | $250K |
| Somatuline Depot Lanreotide Acetate | 71 | 71 | Under 11 | $704K |
| Eliquis Apixaban | 40 | 70 | 14 | $39K |
| Xarelto Rivaroxaban | 40 | 48 | Under 11 | $26K |
| Prednisone Generic | 32 | 32 | 12 | $112 |
| Oxycodone Hcl Generic | 24 | 24 | Under 11 | $683 |
| Brukinsa Zanubrutinib | 20 | 20 | Under 11 | $292K |
| Warfarin Sodium Generic | 19 | 37 | Under 11 | $78.67 |
| Anastrozole Generic | 18 | 44 | Under 11 | $372 |
| Revlimid Lenalidomide | 17 | 17 | Under 11 | $199K |
| Zolpidem Tartrate Generic | 17 | 25 | Under 11 | $248 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 16 | 20 | Under 11 | $201 |
| Xgeva Denosumab | 16 | 16 | Under 11 | $47K |
| Alprazolam Generic | 13 | 13 | Under 11 | $144 |
| Reblozyl Luspatercept-Aamt | 13 | 13 | Under 11 | $315K |
Brand drugs: 412 claims; generic drugs: - claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jin S Lee $616 ($616 in general payments such as food, travel and fees) from 21 companies. The largest payer was Aveo Pharmaceuticals, Inc. with $118.
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 2 | $118 |
| Daiichi Sankyo Inc. 4568.T | 6 | $103 |
| GlaxoSmithKline, LLC. GSK | 2 | $38.84 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $28.9 |
| Eisai Inc. 4523.T | 1 | $24.18 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $23.16 |
| Genmab U.S., Inc. GMAB | 1 | $21.69 |
| Astellas Pharma US Inc 4503.T | 1 | $20.79 |
| Janssen Biotech, Inc. JNJ | 1 | $20.33 |
| Genzyme Corporation SNY | 1 | $19.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.